DMIIU vs PH
Drugs Made In America Acquisition II Corp. Unit (DMIIU) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Drugs Made In America Acquisition II Corp. Unit (DMIIU) common stock listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
DMIIU does not have a complete income-statement cache yet.
Latest reported PH revenue for 2026-06-30 was $21.50B. Net income was $3.65B. Revenue was up 8.3% from 2025-06-30 to 2026-06-30. PH currently screens at market cap $91.89B and trailing P/E 27.7.
DMIIU currently screens at market cap $0. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the DMIIU and PH stock pages for the full models.
Not investment advice.